Clinical MS Research Group
Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.
Research Themes
Cambridge Clinical Multiple Sclerosis Research Group is achieving this objective through six themes:
​
-
Personalising Treatments through Big Data and AI
-
Discovering and Proving New Repair therapies
-
Our Visual and MRI Outcome Development Program
-
Studying Children with MS, NMO and related conditions
-
Study ageing in multiple sclerosis
-
Measuring and sustainably addressing healthcare inequalities.
Currently our work is focused on:
-
Improving the availability of data in electonic health records in the UK for MS researchers
-
Using real-world data to answer important questions about how best to use MS therapies
-
Exploring how best to measure remyelination in adults and children with MS
-
Investigating natural remyelination in people with MS
-
Doing clinical trials to identify drugs which promote endogenous remyelination in people with MS
​​
Read more here.
Featured News
Dr Nicholas Cunniffe Joins Multiple Sclerosis Auckland Remyelination Research Webinar
​
10th April 2026
Our Clinical Trials and Remyelination Group lead, Dr Nicholas Cunniffe, was recently offered the opportunity to participate in a live webinar on remyelination research, hosted by Multiple Sclerosis Auckland in New Zealand.
Read more here.
​
Dr Chris McMurran Delivers an Opening Plenary Lecture at the MS Trust Annual Conference 2026
24th March 2026
A proud moment for our team as Ageing and Brain Health Group Lead, Dr Chris McMurran, was invited to deliver an opening plenary lecture at the MS Trust Annual Conference.
Read more here.
Review Published in Brain on the Link Between Ageing and Remyelination
5th January 2026
Our review on the link between ageing and remyelination has been published in Brain. Click through to learn more about the key takeaway messages and access the full article.
Read more here.
​
